Earnings (Loss) Per Share (Tables)

9 Months Ended

Sep. 30, 2020

Schedule of Common Shares Used to Compute Delek's Basic and Diluted Earnings (Loss) Per Share

The following table sets forth the computation of basic and diluted earnings per share.


	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Numerator:
Numerator for EPS
(Loss) income from continuing operations, net of tax	$	(76.9)	$	60.0	$	(285.4)	$	299.0
Less: Income from continuing operations attributed to non-controlling interest	11.2		8.7		29.4		20.3
(Loss) Income from continuing operations attributable to Delek	$	(88.1)	$	51.3	$	(314.8)	$	278.7



Numerator for EPS - discontinued operations


Loss from discontinued operations attributable to Delek	$	—	$	—	$	—	$	(0.8)

Denominator:
Weighted average common shares outstanding (denominator for basic EPS)	73,669,310		75,028,562		73,551,970		76,463,435


Dilutive effect of stock-based awards	—		673,749		—		704,399
Weighted average common shares outstanding, assuming dilution (denominator for diluted EPS)	73,669,310		75,702,311		73,551,970		77,167,834

EPS:
Basic (loss) income per share:
(Loss) Income from continuing operations	$	(1.20)	$	0.68	$	(4.28)	$	3.64
Loss from discontinued operations	—		—		$	—	(0.01)
Basic (loss) income per share	$	(1.20)	$	0.68	$	(4.28)	$	3.63
Diluted (loss) income per share:
(Loss) Income from continuing operations	$	(1.20)	$	0.68	$	(4.28)	$	3.61
Loss from discontinued operations	$	—	—		$	—	(0.01)
Diluted (loss) income per share	$	(1.20)	$	0.68	$	(4.28)	$	3.60

The following equity instruments were excluded from the diluted weighted average common shares outstanding because their effect would be antidilutive:
Antidilutive stock-based compensation (because average share price is less than exercise price)	3,873,055		1,846,919		3,807,699		2,003,283
Antidilutive due to loss	363,603		—		330,412		—
Total antidilutive stock-based compensation	4,236,658		1,846,919		4,138,111		2,003,283